Inoviq Ltd (IIQ)

Currency in AUD
0.420
+0.020(+5.00%)
Closed·
IIQ Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IIQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4000.425
52 wk Range
0.3450.690
Key Statistics
Bid/Ask
0.40 / 0.425
Prev. Close
0.4
Open
0.4
Day's Range
0.4-0.425
52 wk Range
0.345-0.69
Volume
193.76K
Average Volume (3m)
249K
1-Year Change
-25.66%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IIQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Inoviq Ltd Company Profile

INOVIQ Ltd engages in the developing and commercializing of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. Its cancer diagnostic pipeline includes internal and partnered diagnostic tests for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Employees
15
Market
Australia

Compare IIQ to Peers and Sector

Metrics to compare
IIQ
Peers
Sector
Relationship
P/E Ratio
−6.6x26.9x−0.5x
PEG Ratio
−3.740.060.00
Price/Book
2.4x2.1x2.6x
Price / LTM Sales
27.8x1.3x3.3x
Upside (Analyst Target)
-14.2%43.5%
Fair Value Upside
Unlock11.6%6.8%Unlock

Earnings

Latest Release
Feb 20, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
828.43K / --
EPS Revisions
Last 90 days

IIQ Income Statement

FAQ

What Stock Exchange Does Inoviq Trade On?

Inoviq is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Inoviq?

The stock symbol for Inoviq is "IIQ."

What Is the Inoviq Market Cap?

As of today, Inoviq market cap is 46.89M.

What Is Inoviq's Earnings Per Share (TTM)?

The Inoviq EPS (TTM) is -0.07.

From a Technical Analysis Perspective, Is IIQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Inoviq Stock Split?

Inoviq has split 5 times.

How Many Employees Does Inoviq Have?

Inoviq has 15 employees.

What is the current trading status of Inoviq (IIQ)?

As of 09 Aug 2025, Inoviq (IIQ) is trading at a price of 0.42, with a previous close of 0.40. The stock has fluctuated within a day range of 0.40 to 0.43, while its 52-week range spans from 0.35 to 0.69.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.